﻿<?xml version="1.0" encoding="utf-8"?>
<rdf:Description rdf:about="https://catalogues.royalsociety.org:443/CalmView/record/catalog/JV/9/5/12" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>'New York, Washington and San Francisco', 15 - 24 October 2000</dc:title>
  <dc:description>The file contains a copy of Sir John Vane's itinerary and some detailed correspondence related to various topics under discussion during Sir John Vane's trip, including correspondence concerning a 'nascent Nwe York State based biotechnology company' (New-York Biotechnology Inc). There is also correspondence relating to the classification of 'Coxibs', and a detailed proposal by the Biotechnology Study Center at NYU School of Medicine entitled, 'The "Undeveloped Drug" Project', and a review of the 'Synergy Hepatitis Program' (Synergy, Oxford University and Thomas Jefferson University).</dc:description>
  <dc:date>10 March 2000 - 19 October 2000</dc:date>
</rdf:Description>